Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells

Hypertension Research

Volumn 31, Issue 6, 2008, Pages 1257-1267

  Ide, Noriko ^a   Hirase, Tetsuaki ^a   Nishimoto Hazuku, Ai ^a   Ikeda, Yuji ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Chemokine; IP 10; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALPHA CHEMOKINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; BETA GALACTOSIDASE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; NEUTRALIZING ANTIBODY; RENIN; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENESCENCE; UPREGULATION;

ANGIOTENSIN II; CELLS, CULTURED; CHEMOKINE CXCL10; ENDOTHELIAL CELLS; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 48349130529     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1257     Document Type: Article

References (50)

1. Ruiz-Ortega M, Lorenzo O, Rupérez M, et al: Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001; 38: 1382-1387.
2. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900.
3. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 2003; 144: 2179-2133.
4. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
5. Schmidt-Ott KM, Kagiyama S, Phillips MI: The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000; 93: 65-77.
6. Charo EI, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621.
7. Weber C, Schober A, Zernecke A: Chemokines: key regulators of mononuclear cell recruitment in th lerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 1997-2008.
8. Braunersreuther V, Mach F, Steffens S: The specific role of chemokines in atherosclerosis. Thromb Haemost 2007; 97: 714-721.
9. Reape TJ, Groot PH: Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-225.
10. Shin WS, Szuba A, Rockson SG: The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002; 160: 91-102.
11. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo 0, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998; 161: 430-439.
12. Hernández-Presa M, Bustos C, Ortego M, Tutinon J, Ruiz-Ortega M, Egido J: Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-KB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95: 1532-1141.
13. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Circ Res 1998; 83: 952-959.
14. Han Y, Runge MS, Brasier AR: Angiotensin II induces interleukin-6 transcriptation in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcriptation factors. Circ Res 1999; 84: 695-703.
15. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Criculation 2000; 101: 1372-1378.
16. Ito T, Ikeda U, Yamamoto K, Shimada K: Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells. Atherosclerosis 2002; 165: 51-55.
17. Schmeisser A, Soehnlein O, Illmer T, et al: ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expression. Biochem Biophys Res Commun 2004; 325: 532-540.
18. Edgell CJ, McDonald CC, Graham JB: Permanent cell line expressing human factor VIII-ralated antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734-3737.
19. Mach F, Sauty A, brossi, AS, et al: Differential expression of three T lymphcyte-activating CXC chemokines by human atheroma-associated cell. J Clin Invest 1999; 104: 1041-1050.
20. Luster AD, Ravetch IV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987; 166: 1084-1097.
21. García-López MA, Sánchez-Madrid F, Rodríguez-Frade JM, et al: CXCR3. chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells, Lab Invest 2001; 81: 409-418.
22. Bonecchi R, Bianchi G, Bordignon PP, et al: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134.
23. Hillyer P, Mordelet F, Flynn G, Male D: Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 2003; 134: 431-441.
24. Romagnani P, Annunziato F, Lasagni L, et al: Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001; 107: 53-63.
25. Hirase T, Kawashima S, Wong E, et al: Regulation of tight junction permeability and occuludin phosphorylation by RhoA-p160ROCK-dependent and -independent mechanisms. J Biol Chem 2001; 276: 10423-10431.
26. Fenton M, Barker S, Kurz DJ, Erusalimsky JD: Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol 2001; 21: 220-226.
27. Bonacchi A, Romagnani P, Romanelli RG, et al: Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and - phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 2001; 276: 9945-9954.
28. Shahabuddin S, Ji R, Wang P, et al: CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am J Physiol Cell Physiol 2006; 291: C34-C39.
29. Taub DD, Lloyd AR, Conlon K, et al: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177: 1809-1814.
30. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52: 639-672.
31. 2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res 1997; 80: 139-146.
32. Akishita M, Nagai K, Xi H, et al: Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats. Hypertension 2005; 45: 1188-1193.
33. Wassmann S, Czech T, Eickels M, Fleming I, Böhm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 3062-3067.
34. Candido R, Allen TJ, Lassila M, et al: Irbesartan but not amlodipine suppressm diabetes-associated atherosclerosis. Circulation 2004; 109: 1536-1542.
35. Mateo T, Abu Nabah YN, Abu Taha M, et al: Angiotensin II-induced mononuclear leukocyte interactions with arteriolar different CC chemokines. J Immunol 2006; 176: 5577-5586.
36. Tamassia N, Calzetti F, Ear T, et al: Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and-IFN-γ in human neutrophils. Eur J Immunol 2007; 37: 2627-2634.
37. Suzuki Y, Gómez-Guerrero C, Shirato et al: Susceptibility to T cell - mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway.J Immunol 2002: 169: 4136-4146.
38. Veillard NR, Steffens S, Pelli G, et al: Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 2005; 112: 870-878.
39. Malhotra R, Sadoshima J, Brosius PC III, Izumo S: Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res 1999; 85: 137-146.
40. Bader M, Peters J. Baltatu O, Muller DN, Luft FC, Ganten D: Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 2001; 79: 76-102.
41. Kei K, Hiromi R. Michiko N, et al: Insulin-mediated regulation of the endothelial renin-angiotensin system and vascular cell growth. J Hypertens 2004; 22: 121-l27.
42. Xiao F, Puddefoot M Vinson GP: The expression of renin and the formation of angiotensinII in bovine aortic endothelial cells. J Endocrinol 2000; 164: 207-214.
43. + T-lymphocyte migration stimulated by interferon-γ-inducible prowin-10. Biochemistry 2005; 70: 652-656.
44. Kouroumalis A, Nibbs RJ, Aptel H, Wright KL, Kolios G, Ward SG: The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate Ga-independent signaling and actin responses in human intestinal myfibroblasts. J Immunol 2005; 175: 5403-5411.
45. Shen Q, Zhang R, Bhat NR:, MAP kinase regulation of IP10/CXCL10 chemokine gene expresion in microglial cells. Brain Res 2006; 1086: 9-16.
46. Indraccolo S, Pfeffer U, Minuzzo S, et al: Identification of genes selectively regulated by IFNs, in endothelial cells. J Immunol 2007; 178: 1122-1135.
47. Bodnar RJ, Yates CC, Wells A: IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006; 98: 617-625.
48. Liu X, Shi Q, Sigmund CD: Interleukin-1beta attenuates renin gene expression via a mitogen-activated protein kinase kinase-extracellular signal-regulated kinase and signal transducer and activator of transcription 3-dependent mechanism in As4.1 cells. Endocrinology 2006; 147: 6011-6018.
49. Baumann H, Wang Y, Richards CD, Jones CA, Block TA, Gross KW: Endotoxin-induced renal inflammatory response. J Biol Chem 2000; 275: 22014-22019.
50. Brasier AR, Recinos A III, Eledrisi MS: Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002; 22: 1257-1266.